GL1X · GenesisL1 explorer

MolNFT v1 · #173325 · protein

Crystal structure of oxa-48 beta-lactamase in the complex with the inhibitor ID3

7AW5: “Crystal structure of oxa-48 beta-lactamase in the complex with the inhibitor ID3”. X-ray diffraction, 2 ligands (LKH, CL), 1 pocket (best druggability 0.78). MolNFT v1 #173325 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
7AW5
Type
protein
Length
483 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q6XEC0
Ligands
LKH, CL
Pockets
1 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein24240% helix, 21% strandQ6XEC0
BBeta-lactamase (EC 3.5.2.6)protein24140% helix, 20% strandQ6XEC0

Ligands and binding sites

  • LKH · 4-[(~{E})-[3-(4-chlorophenyl)-5-sulfanylidene-1~{H}-1, 2,4-triazol-4-yl]iminomethyl]benzoic acid · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18880.780.81123CL, LKH

Interfaces

1 interface between chains.

  • A–B · 976 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (carboxylation).

Compared structures

  • 7AW5 · Crystal structure of OXA-48 beta-lactamase in the complex with the inhibitor ID3 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.